Acute pancreatitis associated with irbesartan therapy [3]

Pancreas

Volumn 31, Issue 3, 2005, Pages 294-295

  Famularo, Giuseppe ^a   Minisola, Giovanni ^a   Nicotra, Giulio Cesare ^a   De Simone, Claudio ^b  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; IRBESARTAN; LOSARTAN;

ACUTE PANCREATITIS; AGED; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ECHOGRAPHY; HUMAN; HYPERTENSION; LETTER; MALE; PANCREAS INJURY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPTOMATOLOGY;

ACUTE DISEASE; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BIPHENYL COMPOUNDS; HUMANS; HYPERTENSION; MALE; PANCREATITIS; TETRAZOLES;

EID: 25844518979     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000178281.58158.64     Document Type: Letter

References (10)

1. Fisher AA, Bassett ML. Acute pancreatitis associated with angiotensin II receptor antagonists. Ann Pharmacother. 2002;36:1883-1886.
2. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
3. Bosch X. Losartan-induced acute pancreatitis. Ann Intern Med. 1997;127:1043-1044.
4. Birck R, Keim V, Fiedler F, et al. Pancreatitis after losartan. Lancet. 1998;351:1178.
5. Anagnostopoulos GK, Kostopoulos P, Tsiakos S, et al. Fulminant pancreatitis associated with ramipril therapy. Pancreas. 2003;27:278-279.
6. Tsang SW, Cheng CH, Leung PS. The role of the pancreatic rennin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. Regul Pept. 2004;119:213-219.
7. Tsang SW, Ip SP, Leung PS. Prophylactic and therapeutic treatments with AT1 and AT2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol. 2004;36:330-339.
8. Ip SP, Tsang SW, Wong TP, et al. Saralasin, a nonspecific angiotensin II receptor antagonist, attenuates oxidative stress and tissue injury in cerulein-induced acute pancreatitis. Pancreas. 2003;26:224-229.
9. Tsang SW, Ip SP, Wong TP, et al. Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis. Regul Pept. 2003;111:47-53.
10. Ciaka C, Buclin T, Brunner HR, et al. Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonist. Clin Pharmacokinet. 1997;1:1-29.